BioZorb Lawsuit

Since several BioZorb lawsuits were first filed in November 2024, more women have come forward claiming that the BioZorb 3D Bioabsorbable Marker, a device used in breast cancer surgery, caused serious complications. The lawsuits argue that the company failed to warn them of the risks. They also raised concerns about the BioZorb Marker’s design, manufacturing and marketing.

According to a report to the U.S. Securities and Exchange Commission, there were about 100 cases as of early 2025. One lawsuit is in Massachusetts state court, while the rest are in federal court in Massachusetts. Although these cases are not part of a multidistrict litigation (MDL), having multiple lawsuits in the same federal court can still streamline legal proceedings.

Four bellwether trials are planned, with the first to begin on Sept. 8, 2025. A bellwether trial is a test case that helps predict the outcome of a larger group of similar lawsuits. Courts often use bellwether trials in mass personal injury cases, where the same product or incident injures many people.

Hologic denies any wrongdoing and plans to defend itself. However, litigation can be expensive and unpredictable. At this early stage, the company cannot say how the courts or the parties will resolve these cases.

The BioZorb Marker is a small device that helps doctors identify specific soft tissues for future medical treatments. It has two main parts: one is made of a durable titanium metal that stays in the body permanently. The other part is made of a special plastic that eventually breaks down and gets absorbed by the body over time.

The marker is typically used to highlight the site of a tumor or cancer that was removed, but some women report that the device moved within the body or ruptured through the skin.

In March 2024, Hologic Inc. announced a Class 1 recall of its BioZorb Marker — the most serious recall level. By October 2024, the company issued an additional recall to remove all unused BioZorb devices from the market.

At the time of the second BioZorb recall, Hologic said that nearly 200 people had reported BioZorb complications to the company.

The FDA promised to keep a close eye on adverse event reports and continue to share updates as more information becomes available.

You may qualify to file a BioZorb lawsuit if you had the device implanted after breast cancer surgery and suffered severe complications.

To file a BioZorb lawsuit, you’ll need to gather evidence, find an attorney specializing in medical device lawsuits and beat the deadline to file a lawsuit.

Lawyers who deal with personal injury cases, like those related to BioZorb, usually only get paid if they win your case. Consultations with these lawyers are usually free, but check with the lawyer first to confirm how their payment process works.

If you or someone you care about is going through breast cancer treatment or experiencing complications with the BioZorb Marker, finding trustworthy resources can be helpful. Here are five reliable online platforms that offer support, valuable information and advice for those impacted by these issues.

If you need information about health, support from others or legal help, these resources can be a good way to start. It’s important to stay informed and connected while going through breast cancer treatment and any difficulties that may arise.